Differential myocardial gene expression in the development and rescue of murine heart failure.
about
A thioredoxin fold protein Sh3bgr regulates Enah and is necessary for proper sarcomere formation.Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophyRegulation of motility of myogenic cells in filling limb muscle anlagen by Pitx2.Mammalian enabled (Mena) is a critical regulator of cardiac function.The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure.Fibrosis, not cell size, delineates beta-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo.G protein coupled receptor kinases as therapeutic targets in cardiovascular disease.Genomes, proteomes, and the central dogma.Transcriptomic profiling of the canine tachycardia-induced heart failure model: global comparison to human and murine heart failure.Molecular genetics and genomics of heart failure.Inclusion of biomarkers for detecting perturbations in the heart and lung and lipid/carbohydrate metabolism in National Toxicology Program studies.Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heartPeriostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart.Global expression profiling identifies a novel biosignature for protein aggregation R120GCryAB cardiomyopathy in mice.Cardiac overexpression of Mammalian enabled (Mena) exacerbates heart failure in mice.Decreased beta-adrenergic responsiveness following hypertrophy occurs only in cardiomyocytes that also re-express beta-myosin heavy chainMena associates with Rac1 and modulates connexin 43 remodeling in cardiomyocytesTaking the heart failure battle inside the cell: small molecule targeting of Gβγ subunitsTargeting GRK2 by gene therapy for heart failure: benefits above β-blockade.Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats.Cardiac transcriptional response to acute and chronic angiotensin II treatments.Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies.G Protein-Coupled Receptor-G-Protein βγ-Subunit Signaling Mediates Renal Dysfunction and Fibrosis in Heart Failure.Structural and functional plasticity in long-term cultures of adult ventricular myocytesSimultaneous adrenal and cardiac g-protein-coupled receptor-gβγ inhibition halts heart failure progression.Undercarboxylated matrix Gla protein is associated with indices of heart failure and mortality in symptomatic aortic stenosis.Upregulation of cardiac matrix Gla protein expression in response to hypertrophic stimuli.Enhanced calcium cycling and contractile function in transgenic hearts expressing constitutively active G alpha o* protein.Novel targets of ANG II regulation in mouse heart identified by serial analysis of gene expression.A personalized, multiomics approach identifies genes involved in cardiac hypertrophy and heart failure.Physiological genomics of cardiac disease: quantitative relationships between gene expression and left ventricular hypertrophy.
P2860
Q30009152-76688466-CBD3-4879-A2B8-B892EC8540E2Q33765289-6176BB6D-12B6-4493-8350-9DF8EA923159Q34256759-935758C9-92E3-40E3-8FA6-946D4D823FF8Q34979743-87A63784-EE8E-4348-BC2F-B8EB2AC94938Q35065245-832B8400-91E3-4907-B85A-87266B7761CBQ35110788-0042B461-B44E-432C-B16B-358263FF37DDQ35135090-00776F0E-A7B0-4075-8323-6412A4A00351Q35436208-5136EF57-F82B-41E7-9646-1F84BA32D379Q35851026-A7A8EBDC-65E4-4244-8F02-203059D9B4EFQ35936390-2E3AF525-CF2E-47BD-8BEC-7E8E3FE3DF14Q36148595-72C15EF8-8651-4099-B58B-8D5A9CB28950Q36726587-70BD1499-0973-4D1A-A5F0-0E6498A3652EQ36940602-5BEE92AF-E51C-4C71-856B-A1E15AA75D5AQ36956214-1A9703E1-34D5-405D-8FFC-2E5D2703247BQ37142782-BD90135D-8001-4E0F-B2DE-2E526ECB3045Q37239720-B04ED1F7-8363-4B3F-AFE6-E0996A659CB8Q37575967-F2479D18-7FF9-43B2-AA8F-57215B31213BQ37831634-D5147DA1-F1D1-4F11-8AAE-B45C6E4F05B6Q37984182-C6434EE8-795F-4041-A7DD-5C947A4C124DQ38521114-B69195D1-0556-44B3-8D44-DC653BD09217Q38521958-047656C2-FF24-4245-8004-2E585096516EQ39107039-E16F7F64-9F88-47E0-A857-535A75F99432Q39685882-5E347B19-E9C8-40EF-AF0A-4DBFF8428AFCQ41856871-F46E5779-58D6-41AA-A856-0D93E6A76D9BQ41974755-4E697B45-11F1-4421-82C6-547A7509319EQ42922255-8E7FA8BB-C65C-4E9B-8853-4C012B3F5D1AQ43240494-6DCEA84E-7909-45E0-8E79-EF057F5B361EQ43725907-F015778D-CC7F-45AA-B0C0-757FFF97F480Q47225662-784690FF-A001-49E2-B2DF-0D80560B7E00Q50420738-A3A01AAE-3D96-41C7-A4B4-616A52A859F5Q54592719-C1C6AE17-9849-436D-8D8D-AD1A4A95D6D9
P2860
Differential myocardial gene expression in the development and rescue of murine heart failure.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Differential myocardial gene e ...... escue of murine heart failure.
@en
Differential myocardial gene e ...... escue of murine heart failure.
@nl
type
label
Differential myocardial gene e ...... escue of murine heart failure.
@en
Differential myocardial gene e ...... escue of murine heart failure.
@nl
prefLabel
Differential myocardial gene e ...... escue of murine heart failure.
@en
Differential myocardial gene e ...... escue of murine heart failure.
@nl
P2093
P2860
P1476
Differential myocardial gene e ...... escue of murine heart failure.
@en
P2093
Burns C Blaxall
Howard A Rockman
Rainer Spang
Walter J Koch
P2860
P304
P356
10.1152/PHYSIOLGENOMICS.00087.2003
P577
2003-10-17T00:00:00Z